What to Bring to Your First PMOS Appointment

Key takeaways

• A record of your cycle dates over several months is the single most useful thing to bring.

• Diagnosis of polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS) works by ruling things out as well as ruling them in, so the first appointment may not end in an answer.

• Symptoms you might not connect to your cycles are often relevant.

• Writing questions down beforehand matters more than it sounds — appointments are short.

• None of this is self-assessment. It is preparation so a clinician has what they need.

The most useful thing to bring to a first PMOS appointment is a record of your cycle dates over several months, because cycle length and regularity are among the first things a clinician asks about and the hardest to reconstruct from memory. Bring a symptom list, your family history, and written questions. Expect an assessment that may take more than one visit.

Why cycle dates matter most

Because one of the three diagnostic features is defined by them.

Diagnosis in adults requires two of three features: hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology on ultrasound or elevated anti-Müllerian hormone, after other causes are excluded.1 Ovulatory dysfunction is usually assessed first through cycle pattern.

The guideline defines irregular cycles by specific thresholds that depend on how long it has been since a first period (DOI: 10.1210/clinem/dgad463) — for someone more than three years past menarche and not yet in perimenopause, cycles shorter than 21 days, longer than 35 days, or fewer than eight cycles a year.1

Answering « are your periods regular? » accurately is difficult from memory. A dated record answers it precisely, and it is information nobody else can supply.

What to bring: start dates for as many recent cycles as you have. Six months is genuinely useful.

Three is better than none. If you have been tracking in an app, an exported summary works.

What else is commonly asked about

The condition involves more than cycles, which is part of why it was renamed. A clinician will usually ask about several areas at once.

The last two matter more than people expect. Some medications affect cycles or hormone results, and a clinician needs to know what is already in the picture. Previous results can also save repeating a test.

What usually happens at the appointment

The guideline’s diagnostic approach involves excluding other causes before confirming PMOS.1 In practice that often means the first visit is the start of an assessment rather than the end of one.

Other conditions can produce similar features — thyroid and prolactin problems among them — and they are usually checked before a PMOS diagnosis is settled.1 That is not delay for its own sake. It is how a diagnosis becomes reliable, and it is why a clinician may order tests before saying anything definite.

Two things follow. A first appointment that ends without an answer has not gone badly. And it is reasonable to ask what is being ruled out and why, because the answer tells you what the plan actually is.

Questions worth writing down

Appointments are short and it is easy to leave with things unasked. These are reasonable to bring:

1. What are you checking for, and what would each result tell us?

2. Do I need an ultrasound, or can this be assessed another way?

3. What would make you consider a different diagnosis?

4. What should I be tracking between now and the next appointment?

5. When should I come back, and what would make me come back sooner?

Writing them down beforehand is the practical difference between asking them and not.

If you have been dismissed before

This is common enough to name directly.

If you have raised these symptoms and been told nothing is wrong, a dated record changes the conversation, because it replaces recollection with information. That does not guarantee a different outcome, but it removes one obstacle.

It is also worth knowing two things the guideline supports. Where irregular cycles and hyperandrogenism are both present, an ultrasound is not required for diagnosis.1 And ovulatory dysfunction can occur in people whose cycles look regular, in which case hormonal assessment is how it is confirmed.1 Regular cycles do not by themselves settle the question.

Asking for a second opinion is a normal part of medical care, not a complaint.

What this means for tracking with Premom

Premom is an ovulation tracking application. It is not intended to diagnose, treat, cure, or prevent any disease, including PMOS. The information provided is for educational purposes and should not replace consultation with a healthcare provider.

What an app is genuinely good for here is the record-keeping part: cycle dates, test results, and temperatures logged in one place over months, in a form you can bring to an appointment.

What it does not do is interpret any of it. Whether a pattern meets a clinical definition, and what it means for you, is a judgment a clinician makes with information an app does not have. The record is an input to that conversation, not a substitute for it.

Log your cycle dates in the Premom app

When to seek care sooner

Speak with a clinician without waiting if:

• Your periods have stopped for three months or more, and you are not pregnant

• You have bleeding that is unusually heavy or prolonged for you

• Symptoms are affecting your daily life or your mood

• You are trying to conceive and are uncertain whether you are ovulating

About PMOS

Polycystic ovary syndrome was renamed polyendocrine metabolic ovarian syndrome (PMOS) by international consensus published in The Lancet on 12 May 2026.2 A three-year transition runs to 2028, and both names remain in clinical use. Your existing records and any prior diagnosis remain valid, and the diagnostic criteria did not change.

If your clinician uses the older name, that is expected during the transition and does not mean they are out of date. Reported prevalence varies with the criteria applied; the 2023 International Evidence-Based Guideline reports 10–13% (DOI: 10.1210/clinem/dgad463).1

References

1. Teede HJ, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447–2469. DOI 10.1210/clinem/dgad463 · PMID 37580314. Recommendation 1.1.1 (irregular cycle definitions).

2. Teede HJ, et al. The Lancet, 12 May 2026. DOI 10.1016/S0140-6736(26)00717-8 · PMID 42119588.